Remus Pharmaceuticals fundamental analysis

REMUS

600

15.80 (-2.57%)
Last updated on 9 Mar, 2026 | 14:36 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Remus Pharmaceuticals Fundamentals

P/E Ratio

24.96

P/B Ratio

2.77

Div. Yield

0.12

Sector P/E

37.68

Sector P/B

1.95

Sec. Div. Yield

82.08

Remus Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 24.96, compared to the sector average of 37.68. Its P/B Ratio stands at 2.77, while the sector’s is 1.95. In terms of returns, the stock offers a Dividend Yield of 0.12%, which is than the sector’s 82.08%.

Remus Pharmaceuticals Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Good

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Good

On its scorecard, Remus Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost